Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities    
Net loss $ (27,438) $ (24,916)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 79,155 66,421
Impairment Charges 14,635   
Stock-based compensation 21,411 17,463
Deferred income taxes (45,188) (16,875)
Change in fair value of obligations in connection with acquisitions (1,289) 1,607
Excess tax benefit from stock options (916) (1,962)
Other non-cash items 5,027 (656)
Change in cash attributable to changes in operating assets and liabilities, net of the impact of acquisitions:    
Accounts receivable, net (32,972) (21,594)
Inventories (31,710) (15,643)
Net investment in sales-type leases (4,206) (1,992)
Other receivables and prepaid expenses (10,516) (535)
Other non-current assets 813 5,943
Accounts payable (615) (9,300)
Other current liabilities 20,005 6,083
Unearned revenues 7,598 6,669
Other non-current liabilities 5,160 5,701
Net cash provided (used) by operating activities (1,046) 16,414
Cash flows from investing activities    
Change in short-term bank deposits 115,959 (179,937)
Purchase of property and equipment (43,799) (20,607)
Cash paid for acquisitions, net of cash acquired (141,706) (8,758)
Purchase of long term investments (3,267)   
Acquisition of intangible assets (2,803) (1,326)
Proceeds from sales of marketable securities 1,634   
Other investing activities (81) 303
Net cash used in investing activities (74,063) (210,325)
Cash flows from financing activities    
Proceeds from short-term debt 50,000   
Payment of obligations in connection with acquisitions (10,795)   
Proceeds from secondary offering, net of expenses    462,942
Proceeds from exercise of stock options 7,587 10,004
Acquisition of non-controlling interest (2,170)   
Excess tax benefit from stock options 916 1,962
Net cash provided by financing activities 45,538 474,908
Effect of exchange rate changes on cash and cash equivalents (1,016) 67
Net change in cash and cash equivalents (30,587) 281,064
Cash and cash equivalents, beginning of period 414,088 133,826
Cash and cash equivalents, end of period 383,501 414,890
Supplemental disclosures of cash flow information:    
Transfer of fixed assets to inventory 1,605 802
Transfer of inventory to fixed assets 6,079 4,712
Fair value of assets acquired, including $6,501 and $3,405 of cash acuired for the nine months ended 2014 and 2013, respectively 346,580 573,007
Less liabilities assumed (17,363) (79,357)
Net acquired assets 329,217 493,650
Cash paid for acquisitions 148,207 12,163
Shares and other consideration 181,010 481,487
Total consideration $ 329,217 $ 493,650